Literature DB >> 17255555

Differentiated human alveolar epithelial cells and reversibility of their phenotype in vitro.

Jieru Wang1, Karen Edeen, Rizwan Manzer, Yongsheng Chang, Shuanglin Wang, Xueni Chen, C Joel Funk, Gregory P Cosgrove, Xiaohui Fang, Robert J Mason.   

Abstract

Cultures of differentiating fetal human type II cells have been available for many years. However, studies with differentiated adult human type II cells are limited. We used a published method for type II cell isolation and developed primary culture systems for maintenance of differentiated adult human alveolar epithelial cells for in vitro studies. Human type II cells cultured on Matrigel (basolateral access) or a mixture of Matrigel and rat tail collagen (apical access) in the presence of keratinocyte growth factor, isobutylmethylxanthine, 8-bromo-cyclicAMP, and dexamethasone (KIAD) expressed the differentiated type II cell phenotype as measured by the expression of surfactant protein (SP)-A, SP-B, SP-C, and fatty acid synthase and their morphologic appearance. These cells contain lamellar inclusion bodies and have apical microvilli. In both systems the cells appear well differentiated. In the apical access system, type II cell differentiation markers initially decreased and then recovered over 6 d in culture. Lipid synthesis was also increased by the addition of KIAD. In contrast, type II cells cultured on rat tail collagen (or tissue culture plastic) slowly lose their lamellar inclusions and expression of the surfactant proteins and increase the expression of type I cell markers. The expression of the phenotypes is regulated by the culture conditions and is, in part, reversible in vitro.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17255555      PMCID: PMC1899340          DOI: 10.1165/rcmb.2006-0410OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  26 in total

1.  Identification of genes differentially expressed in rat alveolar type I cells.

Authors:  Katherine Dahlin; Edward M Mager; Lennell Allen; Zachary Tigue; Lee Goodglick; Madhuri Wadehra; Leland Dobbs
Journal:  Am J Respir Cell Mol Biol       Date:  2004-06-17       Impact factor: 6.914

2.  Receptor for advanced glycation end-products is a marker of type I lung alveolar cells.

Authors:  Madoka Shirasawa; Naoyuki Fujiwara; Susumu Hirabayashi; Hideki Ohno; Junko Iida; Koshi Makita; Yutaka Hata
Journal:  Genes Cells       Date:  2004-02       Impact factor: 1.891

3.  Effect of a reconstituted basement membrane on expression of surfactant apoproteins in cultured adult rat alveolar type II cells.

Authors:  J M Shannon; P A Emrie; J H Fisher; Y Kuroki; S D Jennings; R J Mason
Journal:  Am J Respir Cell Mol Biol       Date:  1990-02       Impact factor: 6.914

4.  The mouse homologue of the human acidic ribosomal phosphoprotein PO: a highly conserved polypeptide that is under translational control.

Authors:  A M Krowczynska; M Coutts; S Makrides; G Brawerman
Journal:  Nucleic Acids Res       Date:  1989-08-11       Impact factor: 16.971

5.  Reversible transdifferentiation of alveolar epithelial cells.

Authors:  S I Danto; J M Shannon; Z Borok; S M Zabski; E D Crandall
Journal:  Am J Respir Cell Mol Biol       Date:  1995-05       Impact factor: 6.914

6.  Improved maintenance of adult rat alveolar type II cell differentiation in vitro: effect of serum-free, hormonally defined medium and a reconstituted basement membrane.

Authors:  H Kawada; J M Shannon; R J Mason
Journal:  Am J Respir Cell Mol Biol       Date:  1990-07       Impact factor: 6.914

7.  Changes in biochemical characteristics and pattern of lectin binding of alveolar type II cells with time in culture.

Authors:  L G Dobbs; M C Williams; A E Brandt
Journal:  Biochim Biophys Acta       Date:  1985-07-30

8.  Phospholipid composition and ultrastructure of A549 cells and other cultured pulmonary epithelial cells of presumed type II cell origin.

Authors:  R J Mason; M C Williams
Journal:  Biochim Biophys Acta       Date:  1980-01-18

9.  Primary human alveolar type II epithelial cell chemokine release: effects of cigarette smoke and neutrophil elastase.

Authors:  Ian R Witherden; Elizabeth J Vanden Bon; Peter Goldstraw; Cathy Ratcliffe; Ugo Pastorino; Teresa D Tetley
Journal:  Am J Respir Cell Mol Biol       Date:  2004-04       Impact factor: 6.914

10.  Conversion of lamellar body membranes into tubular myelin in alveoli of fetal rat lungs.

Authors:  M C Williams
Journal:  J Cell Biol       Date:  1977-02       Impact factor: 10.539

View more
  79 in total

1.  Temporal changes in expression of FoxA1 and Wnt7A in isolated adult human alveolar epithelial cells enhanced by heparin.

Authors:  K B C Apparao; Donna R Newman; Huiying Zhang; Jody Khosla; Scott H Randell; Philip L Sannes
Journal:  Anat Rec (Hoboken)       Date:  2010-06       Impact factor: 2.064

2.  Virus-infected alveolar epithelial cells direct neutrophil chemotaxis and inhibit their apoptosis.

Authors:  Joanna P Rzepka; Anoria K Haick; Tanya A Miura
Journal:  Am J Respir Cell Mol Biol       Date:  2012-02-03       Impact factor: 6.914

3.  Extracellular matrix influences alveolar epithelial claudin expression and barrier function.

Authors:  Michael Koval; Christina Ward; Mary K Findley; Susanne Roser-Page; My N Helms; Jesse Roman
Journal:  Am J Respir Cell Mol Biol       Date:  2009-05-07       Impact factor: 6.914

Review 4.  Stem cells and cell therapies in lung biology and lung diseases.

Authors:  Daniel J Weiss; Jay K Kolls; Luis A Ortiz; Angela Panoskaltsis-Mortari; Darwin J Prockop
Journal:  Proc Am Thorac Soc       Date:  2008-07-15

5.  Uses of Remnant Human Lung Tissue for Mechanical Stretch Studies.

Authors:  N Davidovich; P Chhour; S S Margulies
Journal:  Cell Mol Bioeng       Date:  2013-06-01       Impact factor: 2.321

6.  Histopathological evaluation of the diversity of cells susceptible to H5N1 virulent avian influenza virus.

Authors:  Haru Ogiwara; Fumihiko Yasui; Keisuke Munekata; Asako Takagi-Kamiya; Tsubasa Munakata; Namiko Nomura; Futoshi Shibasaki; Kazuhiko Kuwahara; Nobuo Sakaguchi; Yoshihiro Sakoda; Hiroshi Kida; Michinori Kohara
Journal:  Am J Pathol       Date:  2013-11-06       Impact factor: 4.307

7.  Enhanced proliferation of primary rat type II pneumocytes by Jaagsiekte sheep retrovirus envelope protein.

Authors:  Chassidy Johnson; Sohail Jahid; Dennis R Voelker; Hung Fan
Journal:  Virology       Date:  2011-02-12       Impact factor: 3.616

8.  Stem cells and cell therapies in lung biology and lung diseases.

Authors:  Daniel J Weiss; Ivan Bertoncello; Zea Borok; Carla Kim; Angela Panoskaltsis-Mortari; Susan Reynolds; Mauricio Rojas; Barry Stripp; David Warburton; Darwin J Prockop
Journal:  Proc Am Thorac Soc       Date:  2011-06

9.  Bioinformatics-driven discovery of rational combination for overcoming EGFR-mutant lung cancer resistance to EGFR therapy.

Authors:  Jihye Kim; Vihas T Vasu; Rangnath Mishra; Katherine R Singleton; Minjae Yoo; Sonia M Leach; Eveline Farias-Hesson; Robert J Mason; Jaewoo Kang; Preveen Ramamoorthy; Jeffrey A Kern; Lynn E Heasley; James H Finigan; Aik Choon Tan
Journal:  Bioinformatics       Date:  2014-05-07       Impact factor: 6.937

10.  IL1RL1 asthma risk variants regulate airway type 2 inflammation.

Authors:  Erin D Gordon; Joe Palandra; Agata Wesolowska-Andersen; Lando Ringel; Cydney L Rios; Marrah E Lachowicz-Scroggins; Louis Z Sharp; Jamie L Everman; Hannah J MacLeod; Jae W Lee; Robert J Mason; Michael A Matthay; Richard T Sheldon; Michael C Peters; Karl H Nocka; John V Fahy; Max A Seibold
Journal:  JCI Insight       Date:  2016-09-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.